ImmuCell Corporation (ICCC)
NASDAQ · Healthcare
ImmuCell Corporation Gross Profit 2017–2025
ImmuCell Corporation annual/quarterly gross profit history and growth rate from 2017 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- ImmuCell Corporation gross profit for the quarter ending March 31, 2026 was 4.7 M, a 38.86% increase year-over-year.
- ImmuCell Corporation gross profit for the twelve months ending March 31, 2026 was 13.2 M, a 106.90% increase year-over-year.
- ImmuCell Corporation annual gross profit for 2025 was 11.4 M, a 44.13% increase from 2024.
- ImmuCell Corporation annual gross profit for 2024 was 7.9 M, a 105.23% increase from 2023.
- ImmuCell Corporation annual gross profit for 2023 was 3.9 M, a 49.41% decrease from 2022.
- ImmuCell Corporation annual gross profit for 2022 was 7.6 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
ImmuCell Corporation Gross Profit — FAQ
ImmuCell Corporation (ICCC) gross profit over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is ImmuCell Corporation's gross profit?
ImmuCell Corporation (ICCC) reported gross profit of $11M for fiscal 2025.
Where can I see ICCC's gross profit history?
The chart and table above show ImmuCell Corporation's gross profit by year and by quarter, including the growth rate.